In the specialized field of molecular biology and protein research, the term AP 2 peptide often appears in two distinct scientific context Technical Support Center: Antifungal Peptide 2 (AP2) s. Whethe Angiopep-2 exhibits high blood-brain barrier (BBB) penetration capability and can be used for brain compound delivery. For research use only. We do not sell to r you are investigating the transcription factor activator protein 2 (AP-2) family or exploring the capabilities of the Angiopep-2 synthetic peptide, understanding the precise nature of these molecules is essential for accurate experimental design.
The Transcription Factor AP-2 Complex
The transcription factor activator protein 2 (AP-2) is a sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. This protein is normally expressed in ectodermally derived vertebrate tissues where it is necessary for normal growth and development.
In many laboratory settings, researchers utilize an AP2 alpha peptide—a synthesized peptide derived from human AP2 alpha—to validate antibody specificity. These peptides usually contain the epitope recognized by the antibody. By pre-incubating the antibody with the corresponding peptide, one can effectively block specific binding, confirming that the observed signal in techniques like Western blotting or immunohistochemistr Full Name, adipose differentiation-related protein ; Calculated Molecular Weight, 48 kDa ; Observed Molecular Weight, 45-48 kDa ; GenBank Accession Number y is genuine.
Key Functional Characteristics:
* Morphogenesis: AP-2 alpha is required for Anti-AP2 alpha + beta antibody [A6/2/2] (ab61) normal growth and morphogenesis during mammalian development and is specifically the only AP-2 protein required for early morphogenesis of the lens vesicle.
* Gene Regulation: It functions as a sequence-specific DNA-binding protein, influencing c AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter ellular processes by regulating gene expression.
* Clinical Research Parameters: Research suggests that AP-2 may suppress trophoblast migration and invasion, which is a focal point in studies regarding placental development.
The Clathrin-Associated AP2 Complex
Distinct from the transcription factor is the AP-2 adaptor protein complex, which is a heterotetramer consisting of two large adaptins (alpha or beta), a medium adaptin (mu), and a small adaptin (sigma). This complex is involved in clathri Angiopep-2 is a synthetic peptide able to specifically interact with low-density lipoprotein receptor-related protein 1 (LRP1) receptors present both on n-dependent endocytosis, in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs).
The clathrin-associated AP2 peptide is known to inhibit clathrin assembly, providing a useful tool for studying vesicle trafficking. Furthermore, the AP-2 complex has important roles in functional axogenesis by supporting the proper extension of axons and the formation of the Axon Initial Segment (AIS) during early developmental s The peptide is used to block Anti-AP2 gamma Antibody (orb224022) reactivity. Research Area. Epigenetics. Images & Validation. −. tages.
Angiopep-2: A Synthetic Breakthrough
When discussing the term "AP2" in the context of transport and delivery, one must distinguish it from the Angiopep-2 synthetic peptide. Angiopep-2 exhibits high blood-brain barrier (BBB) penetration capability and is widely utilized in research to interact with low-density lipoprotein receptor-related protein 1 (LRP1) receptors.
Unlike the transcription factor-related sequences, Angiopep-2 is designed for its unique ability to cross biological barriers, making it a significant entity in molecular delivery studies. It is often evaluated alongside other A short peptide derived from zebrafish AP-2 complex cell-penetrating peptides, such as the short-length AP (a cell-penetrating peptide), which is noted for having comparatively low immunogenicity.
Practical Considerations for Laboratory Use
Whether you are working with an AP2 gamma peptide—often used to block Anti-AP2 gamma Antibody (orb224022) reactivity—or a mouse monoclonal transcription factor AP-2-alpha antibody, the following points remain critical:
1. Validation: Always ensure the peptide used for blocking matches the specific immunogen sequence of your antibody.
2. Specificity: Remember that AP-2 is a subunit of the AP-2 adaptor protein complex, and cross-reactivity can occur if sequences are not carefully selected.
3. Contextual Application: Be aware of the distinction between the transcription factor (often associated with adipose differentiation-related protein in specific assays) and the endocytic adaptor complex.
By maintaining high standards in reagent selection and understanding the underlying biological pathways—from clathrin-dependent endocytosis to transcription regulation—researchers can achieve more reliable and reproducible results. Always verify the specific molecular weight and sequence data provided by your supplier to ensure your experimental setup matches the intended target.